Healthcare
WHO Assembly Focuses on Political Prosecution of Israel, Forgets about COVID-19
You would think that the current session of the World Health Organization assembly would have focused entirely on the COVID-19 pandemic. Well… think again. The diplomats attending the world body annual meeting, held a four-hour session focused on Israel, which saw itself condemned in speeches by some 30 delegations, including Iran, Syria, North Korea, Cuba, Malaysia, Lebanon, and Venezuela, for allegedly violating the health rights of Palestinians and Syrians in the Golan Heights.
The session concluded with a vote of 78 to 14, with 32 abstentions, to adopt a resolution, co-sponsored by Syria, Cuba, Turkey, Qatar, and the Palestinian delegation, requiring the WHO to hold the same debate at next year’s assembly, and to prepare another report on the “Health conditions in the occupied Palestinian territory, including east Jerusalem, and in the occupied Syrian Golan.”
While the entire world is waiting for WHO to address its own shortcoming and failures to identity and prevent the spread of COVID-19, as well as to forge a global discussion on how to deal with the current pandemic that has caused 1.3 million deaths, the World Health Organization instead focuses its resources on targeting Israel. Unbelievable!
“Today’s four-hour assault on Israel at the WHO promoted the lie that Israel is harming Palestinian health rights,” said Hillel Neuer, the Executive Director of UN Watch. “The opposite is true.”
“Despite the conflict, Israel grants entry to tens of thousands of Palestinians who receive top-level medical care at Israeli hospitals. Even the UN’s own Middle East peace envoy hailed Israel’s ‘excellent’ coordination and cooperation with Palestinians amid the coronavirus pandemic,” said Neuer.
“Israeli medical teams coordinate with Palestinian medical professionals to provide training and assistance. Israel transfers medical equipment and has trained dozens of Palestinian doctors, nurses, and medical personnel from Gaza,” Neuer added.
🇸🇾 Syria just took the floor at the WHO to condemn Israel: “Israeli practices in the Golan impact Syrians’ health and keep them from completing their education in medical schools. Israeli mines in occupied Syrian villages & the dumping of toxic waste seriously threaten children.” pic.twitter.com/BM1w1cZBMT
— UN Watch (@UNWatch) November 12, 2020
Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:
The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.
“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”
“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.
The Daily Caller reports:
According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.
The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.
Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.
-
Immigration5 days agoMigrants refuse to go to Brooklyn cruise terminal shelter, return to Manhattan hotel
-
Immigration4 days agoTexas Governor hires ‘border czar’ to accelerate wall construction
-
China1 day agoChinese Spy Balloon: Tensions rise between the U.S. and China
-
Immigration4 days agoCongressman Biggs to Unveil Impeachment Articles Against DHS Secretary Alejandro Mayorkas
